Browsing Tag
Dermatology
41 posts
Can Glenmark Pharmaceuticals’ FDA approval for Enstilar Foam generic boost its U.S. dermatology footprint?
Glenmark Pharmaceuticals secures FDA approval for its generic version of Enstilar Foam, aiming to expand its U.S. dermatology market presence.
Pulse Biosciences fails to get FDA’s expanded approval for CellFX System
The US Food and Drug Administration (FDA) has rejected an application of Pulse Biosciences is seeking expansion to…
Perrigo acquires skincare and hair loss treatment brands from Sanofi
Ireland-based Perrigo Company has agreed to acquire three over-the-counter (OTC) skincare and hair loss treatment brands sold across…
Lira Style launches Cervello laser hair removal platform
Chicago-based medical device company Lira Style has launched a new laser hair removal platform called the Cervello. Lira…
Lilly to acquire US dermatology drug company Dermira for $1.1bn
Lilly acquisition of Dermira : US pharma giant Eli Lilly and Company (Lilly) has agreed to acquire California-based…
Janssen to acquire skin disease drug candidate bermekimab from XBiotech
Janssen Biotech acquisition of bermekimab: Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, has agreed to…
Foamix Pharmaceuticals bags AMZEEQ FDA approval for moderate to severe acne
AMZEEQ FDA approval : Israeli specialty pharma company Foamix Pharmaceuticals has bagged approval from the US Food and…
Almirall completes $550m acquisition of five dermatology brands from Allergan
In a significant move within the pharmaceutical industry, Spanish pharmaceutical company Almirall has finalised its $550 million acquisition…
Aurobindo Pharma to acquire Sandoz US dermatology and oral solids divisions for $1bn
Aurobindo Pharma, a prominent Indian pharmaceutical company, has agreed to a significant acquisition from Sandoz US, a division…
Sandoz US to divest dermatology and oral solids businesses to Aurobindo Pharma for $1bn
In a strategic move within the pharmaceutical industry, Sandoz US, a subsidiary of the Swiss-based Novartis, has announced…